Menu
0
Total price
0 €
PRICES include / exclude VAT
Homepage>BS ISO 25720:2009 Health informatics. Genomic sequence variation markup language (GSVML)
sklademVydáno: 2009-10-31
BS ISO 25720:2009 Health informatics. Genomic sequence variation markup language (GSVML)

BS ISO 25720:2009

Health informatics. Genomic sequence variation markup language (GSVML)

Format
Availability
Price and currency
Anglicky Secure PDF
Immediate download
373.88 €
You can read the standard for 1 hour. More information in the category: E-reading
Reading the standard
for 1 hour
37.39 €
You can read the standard for 24 hours. More information in the category: E-reading
Reading the standard
for 24 hours
112.16 €
Anglicky Hardcopy
In stock
373.88 €
Označení normy:BS ISO 25720:2009
Počet stran:144
Vydáno:2009-10-31
ISBN:978 0 580 57423 8
Status:Standard
DESCRIPTION

BS ISO 25720:2009


This standard BS ISO 25720:2009 Health informatics. Genomic sequence variation markup language (GSVML) is classified in these ICS categories:
  • 35.240.80 IT applications in health care technology

This International Standard is applicable to the data exchange format that is designed to facilitate the exchange of the genomic sequence variation data around the world, without forcing change of any database schema. From an informatics perspective, GSVML defines the data exchange format based on XML. The scope of this International Standard is the data exchange format, but the database schema itself is outside the scope of this International Standard. From a biological point of view, all genetic sequence variations are taken into consideration and are within the scope of this International Standard, while polymorphisms, especially SNPs, are the main focus of this International Standard. In other words, the annotations of variation as clinical concerns and -omics concerns are within the scope of this International Standard. Though SNPs exist in various biological species, the scope of this International Standard covers the human health associated species as human, cell line, and preclinical animals. The other biological species are outside the scope of this International Standard. The clinical field is within the scope of this International Standard, but the basic research fields and other scientific fields are outside the scope of this International Standard. Here, clinical research, including drug discovery, is within the scope of this International Standard. As for supposed application fields, the main focus is in human health, including clinical practice, preventive medicine, translational research and clinical researches.